1. Pulmonary drug delivery: From generating aerosols to overcoming biological barriers-therapeutic possibilities and technological challenges, Lancet;Ruge;Respir Med.,2013
2. Inhaled Medicines: Past, Present, and Future;Anderson;Pharmacol Rev.,2022
3. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability;Amidon;Pharmaceutical Research: an Official Journal of the American Association of Pharmaceutical Scientists.,1995
4. Drug delivery to the lung: Permeability and physicochemical characteristics of drugs as the basis for a pulmonary biopharmaceutical classification system (pBCS);Eixarch;J Epithel Biol Pharmacol.,2010
5. J.E. Hastedt, P. Bäckman, A.R. Clark, W. Doub, A. Hickey, G. Hochhaus, P.J. Kuehl, C.-M. Lehr, P. Mauser, J. McConville, R. Niven, M. Sakagimi, J.G. Weers, Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD, AAPS Open. 2 (2016) 1–20. https://doi.org/10.1186/s41120-015-0002-x.